Sensible Biotechnologies
The future of mRNA therapeutics is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible enables the next generation of mRNA medicines by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA in a scalable and cost-effective way.
Y Combinator
yc-company-directory #1875The future of mRNA therapeutics is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible enables the next generation of mRNA medicines by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA in a scalable and cost-effective way.
sourceSensible Biotechnologies is classified as Healthcare from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.
Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.
Companies similar to Sensible Biotechnologies
A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.
SynsoryBio
match 49SynsoryBio is creating next generation, protein therapeutics that sense where they are in the body and only activate at diseased tissue. This technology platform has the potential to expand the therapeutic window of highly potent drugs and apply to many diseases such as cancer and autoimmune disorders.
shared product terms: therapeutic, potential, next, generation; shared product theme: health and clinical care; same category: Healthcare; shared affiliation: Y Combinator
Matrubials
match 33Matrubials is an anti-infectives company, focused on human milk peptides as therapeutics to address antimicrobial resistance and modern diseases. Currently the global rise in severe bacterial infections and the drying pipeline of effective treatments are burdensome for healthcare and economics. Sculpted by evolution, milk, first food for the newborn, provides an exemplary solution to address the nutritive and protective challenges an infant is faced with. The anti-pathogenic molecules from milk
shared product terms: therapeutic, challenge, effective; shared product theme: health and clinical care; same category: Healthcare; shared affiliation: Y Combinator
Velorum Therapeutics
match 25Velorum Therapeutics is developing breakthrough medicines by unlocking the biology of heme.
shared product terms: therapeutic, medicine; shared product theme: health and clinical care; same category: Healthcare; shared affiliation: Y Combinator
General Proximity
match 25The next generation of induced-proximity medicines.
shared product terms: next, generation, medicine; shared affiliation: Y Combinator
Engage Bio
match 25Engage Bio has developed Tethosomes, a new class of non-viral DNA which finally unleashes potent, durable, redosable, and scalable genetic medicine. In 2026 Engage was acquired by Eli Lilly.
shared product terms: non, scalable, medicine; shared affiliation: Y Combinator
CB Therapeutics
match 25CB Therapeutics engineers microbes to produce high-value ingredients for medicines, supplements, and other wellness products through sustainable biomanufacturing.
shared product terms: therapeutic, medicine; shared product theme: health and clinical care; same category: Healthcare; shared affiliation: Y Combinator